Human Absorption, Distribution, Metabolism, and Excretion Study of [14C]Adavosertib

Trial Identifier:	D601HC00004
Sponsor:	AstraZeneca
Collaborator:	Parexel
NCTID::	NCT05008913
Start Date:	October 2021
Primary Completion Date:	October 2021
Study Completion Date:	November 2021
Condition:	Cancer - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description
	English Version

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
GB	Manchester, GB, M20 4BX

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.